BBC | Virtus LifeSci Biotech Clinical Trials ETF Overview

(Stock Exchange: AMEX)

Day's Range	29.24 - 29.41
52 Week Range	16.91 - 31.99
Beta	1.00
Implied Volatility	30.71%
IV Rank	72.18%
Day's Volume	473
Average Volume	1,861
Shares Outstanding	388,048
Inception Date	2014-12-17

Assets	10,385,303
Asset Class	Equity
Expense Ratio	0.79
P/E Ratio	N/A
EPS	N/A
Dividend Yield	0.29%
Dividend Per Share	0.08
Dividend ExDate	N/A
Dividend PayDate	N/A

Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

*Chart delayed

Watching at BBC technicals we can see that long-term trend is bullish, the same as bullish middle-term trend, as well as bullish short-term trend. More technicals details can be found on BBC Technicals page.